Skip to content

Evaluation of antioxidant effect of Spirulina platensis in type 2 diabetic patients

Evaluation of oxidative stress biomarkers in type 2 diabetic patients consuming fermented and non-fermented spirulina platensis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220109053671N1
Enrollment
150
Registered
2022-02-13
Start date
2022-02-20
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group: Presenting 8 g of oral Spirulina platensis algae powder in two meals of 4 g per day to the patient for 7 days continuously. Intervention 2: Intervention group: Pres

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: Having type 2 diabetes that is at least 2 years old diabetics

Exclusion criteria

Exclusion criteria: People with type 1 diabetes People under the age of 49 and over 70 years old

Design outcomes

Primary

MeasureTime frame
Mean of fast blood glucose. Timepoint: Day before and eight days after starting the study. Method of measurement: Through special clinical assessment kits.;HS-CRP. Timepoint: Day before and eight day after starting the study. Method of measurement: Through special clinical assessment kits.;Malondialdehyde. Timepoint: Day before and eight days after starting the study. Method of measurement: Through special clinical assessment kits.;Reduced Glutathione. Timepoint: Day before and eight days after starting the study. Method of measurement: Through special clinical assessment kits.;Non-enzymatic antioxidant capacity. Timepoint: Day before and eight days after starting the study. Method of measurement: Through special clinical assessment kits.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Morteza Gharibi

Arak University of Medical Sciences

morteza.qaribi@gmail.com+98 86 3276 0036

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026